Dennis Suskind, Director at CME Group CME, executed a substantial insider sell on April 30, according to an SEC filing.
What Happened: Suskind's decision to sell 1,000 shares of CME Group was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday. The…